MDMXF (Medmix AG) EPS (Diluted): $0.18 (TTM As of Dec. 2025)


MDMXF Medmix AG MDMXF
61 GF Score
Price $17.40
GF Value $26.13
! 7 Warning Signs
View Full Analysis

What is Medmix AG EPS (Diluted)?

Medmix AG MDMXF 61 EPS (Diluted) is $0.18 as of Dec. 2025. GuruFocus rates MDMXF with a GF Score™ of 61/100 and a GF Value™ of $26.13. The stock has 7 warning signs investors should review.

Medmix AG's Earnings per Share (Diluted) for the six months ended in Dec. 2025 was $-0.01. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.18.

Medmix AG's EPS (Basic) for the six months ended in Dec. 2025 was $-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.20.

Medmix AG's EPS without NRI for the six months ended in Dec. 2025 was $0.16. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was $0.24.

During the past 12 months, Medmix AG's average EPS without NRIGrowth Rate was 108.60% per year. During the past 3 years, the average EPS without NRIGrowth Rate was -41.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, Medmix AG's highest 3-Year average EPS without NRI Growth Rate was -2.90% per year. The lowest was -57.60% per year. And the median was -24.80% per year.

Medmix AG  (OTCPK:MDMXF) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Medmix AG EPS (Diluted) Related Terms

Medmix AG EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for Medmix AG's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medmix AG EPS (Diluted) Chart

Medmix AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Diluted)
Get a 7-Day Free Trial 1.16 0.30 0.01 -0.20 0.19

Medmix AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.20 0.13 -0.35 0.20 -0.01

MDMXF vs GEV, ETN, PH: EPS (Diluted) Comparison

For the Specialty Industrial Machinery subindustry, Medmix AG's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medmix AG PE Ratio vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Medmix AG's PE Ratio distribution charts can be found below:

* The bar in red indicates where Medmix AG's PE Ratio falls into.


MDMXF
61GF Score
Medmix AG MDMXF
EPS (Diluted) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medmix AG EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Medmix AG's Diluted EPS for the fiscal year that ended in Dec. 2025 is calculated as

Diluted EPS (A: Dec. 2025 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(8.031-0)/41.512
=0.19

Medmix AG's Diluted EPS for the quarter that ended in Dec. 2025 is calculated as

Diluted EPS (Q: Dec. 2025 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.627-0)/40.959
=-0.02

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Diluted) →
What does a EPS (Diluted) of $0.18 mean?
Medmix AG (MDMXF) has a EPS (Diluted) of $0.18 as of Dec. 2025. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Medmix AG and its competitors.
Is Medmix AG's EPS (Diluted) too high?
Medmix AG's current EPS (Diluted) is $0.18. Overall, Medmix AG has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Medmix AG's EPS (Diluted) compare to GEV and ETN?
Medmix AG's EPS (Diluted) of $0.18 can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for an Industrial Products company?
A good EPS (Diluted) depends on the Industrial Products industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Medmix AG and its competitors. Medmix AG's current EPS (Diluted) is $0.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medmix AG stock overvalued right now?
Medmix AG (MDMXF) has a current EPS (Diluted) of $0.18. The stock's GF Value™ is $26.13, compared to a current price of $17.40 — trading 33.4% below its estimated fair value. The current EPS (Diluted) is $0.18. Medmix AG's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Medmix AG (MDMXF), the current EPS (Diluted) is $0.18 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medmix AG (MDMXF) Overvalued in 2026?

Based on GuruFocus' analysis, Medmix AG stock appears to be undervalued. The current stock price of $17.40 is trading 33.4% below its estimated GF Value™ of $26.13.

Key valuation signals for MDMXF:

  • EPS (Diluted): $0.18
  • GF Value™: $26.13 vs. price of $17.40 (33.4% below fair value)
  • GF Score™: 61/100 with 7 warning signs

No single metric tells the full story. See the MDMXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medmix AG Business Description

Other Exchanges MEDXz:UKMEDX:Switzerland
Address Neuhofstrasse 20, Baar, CHE, 6340
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
61GF Score

Get the complete analysis for MDMXF

EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.40
Price
$26.13
GF Value